DSE : JMISMDL
JMI Syringes & Medical Devices Limited — Key statistics
Surgical and Medical Instruments and Apparatus · Bangladesh
Last price 128.5 BDT (At close: Oct 29, 2026) · Market cap 3.86B
Latest research: JMI Syringes financial analysis: flood write-off, 8.7% gross margin and a BDT 2.00 FY2026 loss per share (Oct 2026) · JMI Syringes: gross margin fell to 8.7% in 9M FY2026 and a flood write-off took FY2026 to a BDT 2.00 loss per share; the 10% cash dividend was kept
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.86B |
| Enterprise Value | 3.78B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 1, 2026 |
| Ex-Dividend Date | Nov 24, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 30.06M |
| Shares Outstanding | 30.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 29.42% |
| Owned by Institutions (%) | n/a |
| Float | 6.12M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.31 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | 49.22 |
| P/OCF Ratio | 43.29 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.26 |
| EV / EBITDA | 40.95 |
| EV / EBIT | 142.07 |
| EV / FCF | 48.21 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.34 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.32 |
| Interest Coverage | 235.54 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -3.61% |
| Return on Assets (ROA) | 0.55% |
| Return on Invested Capital (ROIC) | 1.07% |
| Return on Capital Employed (ROCE) | 1.02% |
| Weighted Average Cost of Capital (WACC) | 4.51% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | -78,984 |
| Employee Count | 1,173 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | 42.26M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +0.08% |
| 50-Day Moving Average | 129.95 |
| 200-Day Moving Average | 129.16 |
| Relative Strength Index (RSI) | 53.32 |
| Average Volume (20 Days) | 9,002 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.67B |
| Gross Profit | 184.77M |
| Operating Income | 26.62M |
| Pretax Income | -50.39M |
| Net Income | -92.65M |
| EBITDA | 91.68M |
| EBIT | 26.62M |
| Loss Per Share | -3.08 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 105.39M |
| Total Debt | 25.46M |
| Net Cash | 79.92M |
| Net Cash Per Share | 2.66 |
| Equity (Book Value) | 2.50B |
| Book Value Per Share | 83.34 |
| Working Capital | 1.32B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 89.22M |
| Capital Expenditures | -10.76M |
| Depreciation & Amortization | 65.05M |
| Net Borrowing | -37.49M |
| Free Cash Flow | 78.46M |
| FCF Per Share | 2.61 |
Margins
| Measure | Value |
|---|
| Gross Margin | 11.04% |
| Operating Margin | 1.59% |
| Pretax Margin | -3.01% |
| Profit Margin | -5.53% |
| EBITDA Margin | 5.48% |
| EBIT Margin | 1.59% |
| FCF Margin | 4.69% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.78% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 38.31% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.78% |
| Earnings Yield | -2.40% |
| FCF Yield | 2.03% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 15, 2022 |
| Split Type | Forward |
| Split Ratio | 1.36 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.89 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |